← Back to Search

Hyaluronic Acid

A-CP HA Kit for Osteoarthritis

N/A
Waitlist Available
Led By Nicholas Sgaglione, MD
Research Sponsored by Regen Lab SA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial shows that for patients with osteoarthritis who haven't found relief from other treatments, a combination of hyaluronic acid and platelet-rich plasma may help.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Variation in overall OA-related symptoms
Variation in pain at walking (WOMAC A1 score)
Secondary outcome measures
% of OMERACT-OARSI responders
Patient's global assessment on a 7-point scale
Patient's global assessment on a 7-point scale at Month 1 (D30), Month 2, Mont 3, Month 4, Month 6, and Month 12 Clinician's global assessment on a 7-point scale
+7 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: A-CP HAExperimental Treatment1 Intervention
Patients randomized in this group will be treated with a combination of platelet-rich plasma plus hyaluronic acid prepared with A-CP HA Kit.
Group II: ArthroVisc 40Active Control1 Intervention
Patients randomized in this group will be treated with hyaluronic acid only (ArthroVisc 40); hyaluronic acid is the same as the one contained in the A-CP HA Kit.
Group III: PlaceboPlacebo Group1 Intervention
Patients randomized in this group will be treated with a saline solution.

Find a Location

Who is running the clinical trial?

Regen Lab SALead Sponsor
11 Previous Clinical Trials
1,125 Total Patients Enrolled
3 Trials studying Osteoarthritis
670 Patients Enrolled for Osteoarthritis
Nicholas Sgaglione, MDPrincipal InvestigatorNorthwell Health
Bert Mandelbaum, MDPrincipal InvestigatorSanta Monica Orthopaedic & Sports Medicine Group

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~42 spots leftby Apr 2025